...
首页> 外文期刊>Revista Brasileira de Hematologia e Hemoterapia >Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhao, Brazil
【24h】

Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhao, Brazil

机译:巴西马拉尼昂州献血者中HTLV-1 / 2的血清阳性率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Infection with human T-lymphotropic virus 1 or 2 (HTLV-1/2) is a major health problem. There is a public health policy defining measures for state hematology and hemotherapy centers in Brazil, in order to avoid virus transmission through blood donors. Objective: This study aimed to evaluate the seroprevalence of HTLV -1/2 in blood donors in the State of Maranhão, Brazil, during routine blood unit screening. Methods: Screening tests of blood donors using the enzyme-linked immunosorbent assay (ELISA) to detect seropositivity for HTLV-1/2 performed at the Hematology and Hemotherapy Center of the State of Maranhão (HEMOMAR) between July of 2003 and December of 2009 were retrospectively evaluated. Results: Of the 365,564 blood donors, 561 (0.15%) were HTLV-1/2-positive, of whom 72 (12.8%) performed the confirmatory test (Western blot). In donors who had a confirmatory test, 53 (73.6%) were positive. The ages of the infected individuals ranged from 18 to 65 years; 305 (54%) were aged over 40 years. Among the infected individuals, 309 (55%) were male, 399 (71%) were mixed-race, and 259 (46%) were single. Co-infections were frequently found, especially with hepatitis B (in 68.6% of the cases). Conclusion: The results obtained will contribute to the planning and implementation of control measures by the epidemiological surveillance agency of Maranhão, and will also contribute to reducing morbidity. The high seropositivity in a small sample in donors who had confirmatory tests indicates the need for confirmatory tests for all donors who initially test as seropositive.
机译:背景:感染人类T淋巴病毒1或2(HTLV-1 / 2)是一个主要的健康问题。有一项公共卫生政策,为巴西的州血液学和血液治疗中心定义了措施,以避免病毒通过供血者传播。目的:本研究旨在评估常规筛查血液单位中巴西马拉尼昂州献血者中HTLV -1/2的血清阳性率。方法:于2003年7月至2009年12月在马拉尼昂州血液和血液治疗中心(HEMOMAR)进行的酶联免疫吸附试验(ELISA)筛查献血者,以检测HTLV-1 / 2的血清阳性。回顾性评估。结果:在365,564名献血者中,有HTLV-1 / 2阳性的有561名(0.15%),其中有72名(12.8%)进行了验证试验(Western blot)。在进行了确证测试的捐献者中,有53例(73.6%)为阳性。感染者的年龄在18至65岁之间。 305岁(54%)的年龄超过40岁。在被感染的个体中,男性为309(55%),混合种族为399(71%),单身者为259(46%)。经常发现合并感染,尤其是乙型肝炎(占68.6%)。结论:获得的结果将有助于马拉尼昂州流行病学监测机构规划和实施控制措施,也将有助于降低发病率。在进行了确证试验的供体中,只有少量样品具有很高的血清阳性率,这表明需要对所有最初呈血清阳性的供体进行确证试验。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号